You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Genetic characterization of Lynch syndrome germline variants in a LATAM cohort using a customized NGS gene panel
- 2. Are Some 'Low-Grade' Prostate Cancers More Deadly Than Thought?
- 3. Oncolytic virus therapy for cancer: what's been going on in 2025?
- 4. Bioinformatics-based prognostic value and in vitro functional validation of PTK6 in cutaneous melanoma
- 5. Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma
- 6. Physical activity and glioblastoma: a paradigm shift in neuro-oncology therapy
- 7. AI-based breast cancer risk technology receives FDA Breakthrough Device designation
- 8. Redefining "normal": discovery of aneuploid epithelial cells in healthy breast tissue
- 9. Polyamine metabolism related gene index prediction of prognosis and immunotherapy response in breast cancer
- 10. BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study
Last updated at 15:04 GMT
Hot News Makers
Health/Pharma Companies
-
2387.00
-
1984.08
-
1531.37
-
1070.54
-
829.30
-
457.30
-
342.98
-
240.56
-
207.86
-
172.75
Drugs, Treatments, Trials
-
1755.15
-
1200.97
-
982.81
-
936.08
-
813.55
-
773.02
-
764.41
-
638.24
-
429.98
-
275.19
Last updated at 14:10 GMT
